Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Invasive Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab|DRUG: Carboplatin|DRUG: Paclitaxel|DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: Atezolizumab|PROCEDURE: Surgery
Sponsor: Fondazione Michelangelo
Collaborators: Hoffmann-La Roche